Lara Stevanato, R&D manager at ANGLE plc
Lara Stevanato possess a PhD in Biotechnology. Lara joined ANGLE PLC in 2016 as R&D project manager for the analytical evaluation of ParsortixTM system as part of the FDA application.
As part of Cancer-ID, I led the protocol development for the CTC isolation and enumeration technology comparison (CANCER-ID Ring Trial ). Prior to joining ANGLE, Lara served as Head of Molecular Biology at ReNeuron, specializing in the development of stem cell-based clinical products.
Lara has more than 20 years of experience in the life science industry focused on the development and translational of clinical products in both the pharmaceutical and diagnostic industries.